Artificial Urinary Sphincter Patient Reviews: Real Experiences

Most men who receive an artificial urinary sphincter (AUS) for stress urinary incontinence report meaningful improvement in their daily lives, with satisfaction rates consistently landing between roughly 75% and 90% across studies spanning decades of follow-up. That headline number, though, flattens a wide range of individual experiences. Some patients describe the device as life-changing; others deal with revisions, mechanical wear, or a learning curve that nobody warned them about. What follows is a close look at what the research actually captures about real patient experiences, from pad counts and emotional health to the long-term realities of living with an implanted mechanical device.

How Satisfied Are Patients, Really?

Satisfaction data across multiple studies paint a broadly positive but nuanced picture. In one well-cited series of 50 patients followed for a median of about two years, 90% reported satisfaction, and 92% said they would have the device placed again. A separate group of 113 patients followed for an average of about six years showed 73% were satisfied or very satisfied, while 10% were dissatisfied or very dissatisfied, and the remainder fell in the middle. Among 71 men tracked for nearly eight years on average, 77% were satisfied or very satisfied, but 23% were not.¹ These numbers help set expectations: most people do well, but a meaningful minority does not reach the outcome they hoped for.

A Canadian study of 34 men asked a question that gets closer to what prospective patients want to know: would you do it again? About 91% said yes, and roughly 82% would recommend it to a friend without reservation.² Those “would you do it again” numbers tend to run higher than simple satisfaction scales, which is worth noting. A patient can be imperfectly satisfied with an outcome and still feel that life is better than before surgery.

Interestingly, men receiving a second or replacement device report quality-of-life scores similar to those with their original implant, suggesting that even patients who go through revision surgery can land in a good place.³

What Happens to Pad Usage

For many patients, the clearest measure of success is the number of pads they go through each day. Before surgery, severe incontinence often means five or more pads daily. A meta-analysis pooling data from over 1,200 patients across 19 studies found that daily pad use dropped by about four pads on average after AUS placement. About 52% of patients achieved complete dryness (zero pads), and roughly 82% reached what researchers call “social continence,” meaning one pad or fewer per day.⁴ That distinction matters for daily life. Many patients who still use a single light security pad consider themselves functionally dry and are quite happy with the result.

A Swedish study that measured actual urine leakage by weight, rather than relying on pad counts, showed the improvement in sharper relief. The median amount of leakage in a 24-hour period dropped from about 494 grams before surgery to just 7 grams afterward.⁵ That is a change from soaking through pads throughout the day to barely registering any leakage at all.

The Emotional Side of Getting an AUS

What patient reviews and forum posts often emphasize, and what clinical studies are finally catching up to, is the psychological weight of incontinence and how profoundly the AUS can lift it. A prospective multi-center study tracked 100 men for a year after implantation using standardized quality-of-life questionnaires. Before surgery, 85% of patients reported feeling at least “a little” depressed due to their incontinence. At 12 months, that had dropped to 39%. The share of men who said incontinence “greatly” affected their emotional health fell from 16% to just 3%. Anxiety and depression scores also improved significantly.⁶

These findings line up with what patients describe informally: the constant worry about leakage in public, the fear of smell, the avoidance of social situations. Removing or even substantially reducing those anxieties has an outsized effect on well-being that goes beyond what a pad count can capture. Research confirms that the improvement in psychological health is durable and extends well beyond the first year after surgery.⁷

Living With the Device Day to Day

The AUS is a mechanical device that requires the patient to physically operate it. To urinate, you squeeze a small pump located in the scrotum, which moves fluid from the cuff around the urethra into a reservoir, temporarily opening the urethra. The cuff then automatically refills over a couple of minutes to restore continence. This sounds straightforward, but the learning curve is a real part of the experience that patients frequently mention.

A 2024 study specifically examined how hand dexterity affects outcomes. About 64% of patients reported no difficulty using the pump, and roughly 54% said they felt confident operating the device within a single day. Nearly 59% described themselves as very satisfied. The study found that a simple clinical pinch-strength test predicted patient satisfaction, while a peg-placement dexterity test predicted how quickly patients gained confidence.⁸ In practical terms, if you can squeeze a small pump between your thumb and fingers with reasonable strength and precision, you’ll probably manage the device without much trouble.

That said, the question of what happens as patients age is one that the medical literature has only recently started to confront. The AUS may function mechanically for years, but the patient’s ability to operate it can decline due to arthritis, neuropathy, or cognitive changes. Available data on AUS durability has mostly focused on mechanical and medical factors, while age-related deterioration in dexterity and cognitive ability that might prevent a patient from operating an otherwise intact device has received little formal study.⁹ This is a gap that patients and families should discuss with their surgeon before implantation, especially for men in their seventies or eighties.

How Long Does the Device Last

Device longevity is one of the first questions patients ask, and the answer depends on what you mean by “last.” The device itself can wear out mechanically, the tissue around the cuff can thin over time (urethral atrophy), or infection or erosion can force removal. Long-term data from a retrospective study of women (one of the longest follow-up series available for AUS) showed a median time before any revision was needed of about 17.5 years. The revision-free survival rate was 86% at 10 years and dropped to 47% at 20 years. The removal-free survival rate, a more dramatic endpoint, was 84% at 10 years and 80% at 20 years.¹⁰

For men, the picture is broadly similar in pattern if not in exact numbers. Studies looking out five to ten years find that many patients are still doing well, though performance can gradually decline. Among patients surveyed five to ten years after surgery, about 36% were using one security pad or fewer daily. At more than ten years out, that figure was 23%. The encouraging detail is that even as pad use crept up with time, around 80% of patients in both time windows still rated their overall condition as “much better” than before surgery.¹¹ The device may lose some of its initial effectiveness over the years, but patients still feel the trade-off was worthwhile.

Complications Patients Should Know About

No implanted device is without risk, and the AUS is no exception. The most commonly discussed complications are erosion (the cuff wearing through the urethra), infection, and mechanical failure. A systematic review of complications in female patients found erosion rates of roughly 5–6%, while infection rates ranged from about 3% to 6% depending on the surgical approach.¹² Rates in men are broadly comparable, though specific numbers vary across series. Erosion and infection typically require removing the device, treating the problem, and waiting months before reimplantation can be considered.

Urethral atrophy is a subtler issue. Over time, the constant pressure of the cuff can cause the tissue underneath to thin, which lets urine leak past even though the device is mechanically intact. This is a common reason patients notice gradually worsening incontinence years after a successful initial result. Revision surgery can address atrophy by downsizing the cuff, repositioning it to healthier tissue, or adding a second “tandem” cuff. Among those options, research from a multicenter study found that adding a tandem cuff was associated with the best outcomes for recurrent incontinence, while simply repositioning the existing cuff to a new site with the same size carried a higher failure rate.¹³

The Radiation Factor

A substantial number of AUS candidates have had radiation therapy for prostate cancer, and this is one area where patient experiences diverge sharply. A meta-analysis examining the impact of prior radiation found that irradiated patients had roughly twice the odds of cuff erosion and about three times the odds of needing the device removed entirely compared to non-irradiated patients. The odds of achieving complete continence were also significantly lower in the radiation group.¹⁴ Radiation damages tissue vascularity and healing capacity, making the urethra more vulnerable to the pressure the cuff exerts.

This does not mean the AUS is off the table for irradiated patients. Many still do well. But the conversation about expectations needs to be more cautious, and the risk of revision or removal is genuinely higher. A recent study also explored timing: patients who had the AUS placed before receiving radiation appeared to have comparable or slightly higher erosion rates than those who received radiation first, though the sample sizes were small enough that firm conclusions are premature.¹⁵ If you are facing both radiation and incontinence surgery, the sequence and timing are worth a detailed discussion with your care team.

How the AUS Compares to a Male Sling

Patients often ask whether a male sling might be a simpler alternative. The MASTER trial, a randomized controlled trial comparing the two approaches, found that the sling was statistically non-inferior to the AUS for continence at 12 months, though the AUS group had slightly better incontinence scores. Quality-of-life improvements and satisfaction were high in both groups. The sling group had fewer serious adverse events. However, secondary outcomes that showed statistically significant differences generally favored the AUS.¹⁶

The practical takeaway is that for moderate incontinence, either option can work well. The sling is a simpler procedure with no moving parts and nothing to manipulate afterward, which appeals to men who are concerned about dexterity or the daily routine of pump operation. The AUS tends to be recommended for more severe incontinence or cases where the sling has already failed. Neither choice is universally superior, and the right answer depends on the severity of leakage, anatomy, prior treatments, and personal preference.

Sexual Function and Intimacy

Incontinence itself is a major barrier to intimacy. Leakage during sex, sometimes called climacturia, causes embarrassment and avoidance that can be as damaging to relationships as the physical symptoms. A study examining sexual satisfaction before and after AUS placement found no significant change in erectile function scores or intercourse satisfaction scores, suggesting the device itself does not harm sexual performance.¹⁷

What does change is how worried patients feel. Data from the prospective AUSCO study found that among men without erectile dysfunction, 43% reported being “extremely” worried about sex due to incontinence before surgery. At 12 months, that had dropped to 12%. The proportion who were “not at all” worried more than doubled, from 19% to 40%. Even among men who did have erectile dysfunction, the worry scores improved, though the sample was smaller. Lower pad use after surgery was associated with greater improvement in sexual quality of life.¹⁸ The AUS does not fix erectile dysfunction, but by controlling leakage, it removes one of the biggest psychological barriers to sexual activity.

Decisional Regret and Managing Expectations

One of the more honest metrics in surgical outcomes research is decisional regret: looking back, do you wish you had made a different choice? A study of AUS patients after radical prostatectomy found that 35% reported zero regret, about 34% had mild regret, and 30% had moderate regret. Severe regret was rare at just over 1%. The strongest predictor of regret was having needed repeat surgery. Patients who went through a revision had, on average, substantially higher regret scores than those whose original device continued to work.¹⁹

This finding underscores a theme that runs through patient experiences: the AUS works well for most people, but the patients who struggle the most are those who needed revision surgery and felt blindsided by the possibility. Thorough preoperative counseling about realistic outcomes, the likelihood of revision over a decade or more, and the factors that increase risk (prior radiation, severe atrophy) can go a long way toward aligning expectations with reality. The literature is consistent that careful patient selection and honest conversation about what the device can and cannot do are essential to a good experience.²⁰

What Future Devices Might Look Like

The current AUS design, the AMS 800, has been in use since the 1980s with relatively minor modifications. It works, but it is entirely mechanical and offers no way to adjust cuff pressure after implantation. Several research groups are developing electronic or “smart” sphincters that could be controlled via a remote or smartphone app, which would eliminate the need for manual pump operation entirely. Beyond convenience, an electronic device could allow timed pressure release during sleep to reduce urethral atrophy, or temporarily increase cuff pressure during exercise or coughing. The concept of adaptive cuff pressures that respond to changes in abdominal pressure is being explored, though the data on its benefits remain early and inconclusive.⁹

For patients currently weighing whether to proceed with the existing device or wait, the honest answer is that next-generation devices are still in development and not yet available for routine clinical use. The current AUS has a long track record and, for most patients, delivers the improvement they need. Waiting years for a hypothetical improvement is a gamble against ongoing incontinence, which has its own cumulative toll on physical and emotional health.